A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder ...
MedPage Today on MSN
Extended-Release Buprenorphine Viable, Safe During Pregnancy
Weekly injections led to higher opioid abstinence rate, with good infant outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results